GT BIOPHARMA, INC. Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate
GT BIOPHARMA, INC. (GTBP) had Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate of 132.00% as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes
us-gaap:LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate · last filed 2021-12-29
- 2021-09-30: Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate 132.00%.
- 2021-06-30: Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate 135.00%.
- 2021-03-31: Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate 136.00%.
- 2020-12-31: Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate 135.00%.
| Period end | Long-Duration Contracts, Assumptions by Product and Guarantee, Volatility Rate |
|---|---|
| 2021-09-30 | 132.00% 10-Q · filed 2021-11-10 |
| 2021-06-30 | 135.00% 10-Q/A · filed 2021-12-29 |
| 2021-03-31 | 136.00% 10-Q · filed 2021-05-17 |
| 2020-12-31 | 135.00% 10-Q/A · filed 2021-12-29 |
| 2020-07-31 | 134.00% 10-K · filed 2021-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |